Zobrazeno 1 - 10
of 35
pro vyhledávání: '"L. M. Jost"'
Summary Purpose To identify prognostic factors in patients with chemosensitive relapsed Hodgkin's disease treated by high-dose chemotherapy with autologous progenitor cell transplantation (HDC) and to compare the duration of treatment-free remission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49059867d9741d4a48073a9272b9e2f0
http://doc.rero.ch/record/291531/files/8-8-785.pdf
http://doc.rero.ch/record/291531/files/8-8-785.pdf
Autor:
Daniel Betticher, Walter Weder, Hans-Beat Ris, Miklos Pless, L. M. Jost, Sandra Thierstein, Roger Kann, Michael Mayer, René O. Mirimanoff, Sabine Balmer Majno, Solange Peters, Abderahim Zouhair, Shu Fang Hsu-Schmitz, Markus Furrer, Ralph A. Schmid, Arnaud D. Roth, Rolf A. Stahel, Roger Stupp
Publikováno v:
The Lancet Oncology. 10:785-793
BACKGROUND: Stage IIIB non-small-cell lung cancer (NSCLC) is usually thought to be unresectable, and is managed with chemotherapy with or without radiotherapy. However, selected patients might benefit from surgical resection after neoadjuvant chemoth
Publikováno v:
Oncology. 59:110-117
The prognosis of germ cell tumors treated with chemotherapy depends on the presence of nonseminomatous tumor, clinical parameters based on the tumor volume and site, as well as on the level of the tumor markers AFP, βHCG and LDH. We report here on t
Autor:
Rolf A. Stahel, Robert Maurer, Borut Marincek, Christian Sauter, Gabriella Pichert, Corina C. Dommann-Scherrer, L. M. Jost, Hanspeter Honegger, Bernhard C. Pestalozzi, Christoph Glanzmann, Emanuel Jacky, Thomas Kroner
Publikováno v:
British Journal of Haematology. 104:763-769
Several centres reported a favourable outcome after high-dose chemotherapy with autologous progenitor cell transplantation in selected patients with high-risk large cell non-Hodkgin's lymphoma in first remission. Based on these observations, we wante
Publikováno v:
Journal of Clinical Oncology. 15:1730-1735
PURPOSE To evaluate the effect of two filgrastim dosages after autologous bone marrow transplantation (ABMT) in patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). PATIENTS AND METHODS Eighty-six patients were enrolled onto a multi
Autor:
L. M. Jost, R. Greil
Publikováno v:
Annals of Oncology. 16:i80-i82
Publikováno v:
Annals of Oncology. 16:i66-i68
Autor:
L. M. Jost
Publikováno v:
Annals of Oncology. 16:i83-i85
Publikováno v:
Blood. 88:3166-3175
The use of ex vivo expanded CD34-selected hematopoietic progenitor cells (HPCs) for autologous stem cell support or gene therapy is a major area of research and is likely to increase in the future. At present, little is known about the fate of contam